These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2067346)

  • 1. [Evaluation of plasmapheresis effectiveness in patients with psoriasis].
    Potekaev NS; Kurdina MI; Gorshkova NN
    Klin Med (Mosk); 1991 Mar; 69(3):80-2. PubMed ID: 2067346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasmapheresis in the therapy of refractive forms of psoriasis].
    Potekaev NS; Kurdina MI; Gorshkova NN; Orlova KE; Shuginina EA; Kriuchkov MI
    Vestn Dermatol Venerol; 1990; (10):35-7. PubMed ID: 2278191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasmapheresis in the combined therapy of psoriasis].
    Sharapova GIa; Sorokin BA; Popov AV; Antiukhov AV; Mashkov OA
    Ter Arkh; 1992; 64(10):83-5. PubMed ID: 1485265
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experience in treating psoriasis patients by plasmapheresis].
    Fel'ker AIa
    Vestn Dermatol Venerol; 1987; (7):56-60. PubMed ID: 3673247
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plasmapheresis intensive therapy of progressing stage of psoriatic disease].
    Rychkov VV; Gonchar-Zaĭkin AP; Vorobeĭkina NA
    Voen Med Zh; 2009 Dec; 330(12):24-6. PubMed ID: 20201365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis].
    Karpina NL; Kaminskaia GO; Serebrianaia BA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2007; (11):33-7. PubMed ID: 18080532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of fibrinogen and von Willebrand factor in serial double-filtration plasmapheresis.
    Lin SM; Yeh JH; Lee CC; Chiu HC
    J Clin Apher; 2003; 18(2):67-70. PubMed ID: 12874818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of plasmapheresis in multimodality correction of hemostasis disorders in patients with calculous pyelonephritis].
    Nemark AI; Mazyrko AV; Astakhov IuI
    Ter Arkh; 1989; 61(6):86-8. PubMed ID: 2799724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation in psoriasis.
    Berrettini M; Parise P; Constantini V; Grasselli S; Nenci GG
    Thromb Haemost; 1985 Apr; 53(2):195-7. PubMed ID: 3161205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral and cellular factors of immunity in patients with torpid and frequently recurring psoriasis treated by the plasmapheresis method].
    Fel'ker AIa; Khamzina OSh; Blinetskaia ZS
    Vestn Dermatol Venerol; 1987; (3):45-8. PubMed ID: 3604433
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of climatotherapy at the Dead Sea for psoriasis vulgaris: A community-oriented study introducing the 'Beer Sheva Psoriasis Severity Score'.
    Cohen AD; Van-Dijk D; Naggan L; Vardy DA
    J Dermatolog Treat; 2005; 16(5-6):308-13. PubMed ID: 16428150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of the disseminated intravascular coagulation syndrome in urosepsis patients].
    Neĭmark AI; Astakhov IuI; Mazyrko AV
    Urol Nefrol (Mosk); 1990; (4):13-7. PubMed ID: 2275053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriasis with plasmapheresis.
    Andersen E; Andresen R; Clemmensen OJ
    Arch Dermatol; 1982 Feb; 118(2):74. PubMed ID: 7059222
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemostatic and vascular parameters in psoriasis. Preliminary study].
    Cabral JM; Monteiro AC; Andrade JA; Fortunato JM; Dias MC; Braga A; Guimarães JM; Resende C; Vaz AL; Araújo D
    Acta Med Port; 1988; 1(3):191-5. PubMed ID: 3202006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in fibronectin concentration during therapeutic plasmapheresis. Therapeutic effectiveness of selective removal of fibronectin in immune complex pathology].
    Vasil'ev SA; Savchenko VG; Gorodetskiĭ VM; Ermolin GA; Kotelianskiĭ VE
    Ter Arkh; 1984; 56(6):35-9. PubMed ID: 6236575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of psoriasis by efferent methods on an outpatient basis].
    Popov AV; Sharapova GIa; Mashkov OA; Sorokin BA; Antiukhov AV; Prokhorov IuS
    Ter Arkh; 1993; 65(1):67-9. PubMed ID: 8036580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of cryoapheresis on the course of immune complex diseases].
    Margulis EIa; Savchenko VG; Zherdeva LV; Tolkachev AA; Selezneva OM
    Ter Arkh; 1987; 59(6):80-5. PubMed ID: 2957815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of lipid peroxidation and of lysosomal hydrolase activity and their correction in psoriasis patients].
    Ivanova IP; Mareeva TE
    Vestn Dermatol Venerol; 1987; (4):26-31. PubMed ID: 3604442
    [No Abstract]   [Full Text] [Related]  

  • 19. [Initial experiences in the treatment of skin diseases using dialysis and plasmapheresis. A new therapy of severe skin diseases].
    Rozsívalová V; Koudelková V; Erben J; Bláha M
    Cesk Dermatol; 1982 Aug; 57(4):197-204. PubMed ID: 6216000
    [No Abstract]   [Full Text] [Related]  

  • 20. [A pathogenetic study of the hemostatic system in patients with severe forms of eczema, atopic dermatitis and psoriasis (a review of the literature and the authors' own data)].
    Khazizov IE; Nodova ES
    Ter Arkh; 1993; 65(11):43-9. PubMed ID: 8108797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.